TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
Qingyu Liao(Chongqing Medical University), Bianqin Guo(Chongqing University)
Cited by 27
Related Papers
PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathway
|Molecular Carcinogenesis|2023|11